UG Q2 2025 Earnings EPS of 014 Reported Stock Climbs as Profitability Holds Steady Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech WSO Q1 2026 Earnings EPS Surpasses Estimates by 933 Stock Declines Marginally PENN Q1 2026 Earnings Steep EPS Miss Amid Operational Headwinds Immunome Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Declines OFS Q1 2026 Earnings Staggering EPS Beat of 475 Surprises Market